HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Aicardi's syndrome — Clinical Guidelines

Overview

Aicardi's syndrome is a rare genetic disorder predominantly affecting females, characterized by agenesis of the corpus callosum, infantile spasms, characteristic ocular anomalies (including chorioretinal lacunae), and often severe developmental delay and mental retardation 1 3 4.

Diagnosis

Key Diagnostic Criteria:

- Agenesis of the corpus callosum - Infantile spasms - Ocular anomalies (e.g., chorioretinal lacunae) - Severe developmental delay and mental retardation

Recommended Tests:

- MRI Brain Imaging: Reveals cortical migration defects (94%) and variability in callosal defects 1 - Neurosonography: Bilateral prominent cysts in the choroid plexus alongside agenesis of the corpus callosum 2 - EEG: Characteristic multifocal epileptiform abnormalities on a burst-suppression pattern showing interhemispheric asynchrony 5

Management

First-Line Treatments:

- Antiepileptic Drugs (AEDs): To manage infantile spasms; specific drugs not detailed but commonly include valproate, vigabatrin, or adrenocorticotropic hormone (ACTH) 3 5

Adjunctive Treatments:

- Early Intervention Programs: For developmental support 3 - Physical and Occupational Therapy: To address motor and functional impairments 3

Special Populations

Pediatrics: Early recognition via neuroimaging and EEG is crucial for timely intervention 1 2 5

Comorbidities: No specific management details provided for comorbidities; focus remains on symptomatic treatment and supportive care 3 4

Key Recommendations

Utilize MRI and EEG for definitive diagnosis of Aicardi's syndrome, identifying characteristic brain abnormalities and EEG patterns 1 5 (Evidence: Strong)

Initiate early antiepileptic therapy targeting infantile spasms to improve seizure control and developmental outcomes 3 5 (Evidence: Moderate)

Implement comprehensive early intervention programs to support developmental delays in affected children 3 (Evidence: Expert opinion)

References

1 Smith CD, Ryan SJ, Hoover SL, Baumann RJ. Magnetic resonance imaging of the brain in Aicardi's syndrome. Report of 20 patients. Journal of neuroimaging : official journal of the American Society of Neuroimaging 1996. link 2 Roland EH, Flodmark O, Hill A. Neurosonographic features of Aicardi's syndrome. Journal of child neurology 1989. link 3 Dinani S, Jancar J. Aicardi's syndrome: (agenesis of the corpus callosum, infantile spasms, and ocular anomalies). Journal of mental deficiency research 1984. link 4 Denslow GT, Robb RM. Aicardi's syndrome: a report of four cases and review of the literature. Journal of pediatric ophthalmology and strabismus 1979. link 5 Fariello RG, Chun RW, Doro JM, Buncic JR, Prichard JS. EEG recognition of Aicardi's syndrome. Archives of neurology 1977. link

Aicardi's syndrome